Oxford Instruments FY25 Profit Down, Orders Edge Up; Lifts Dividend; Says Confident Of Mid-term View

Oxford Instruments (OXIG.L) reported fiscal 2025 revenue exceeding £500 million, a 6.4% increase, and a 1% rise in orders to £463.7 million; however, profit before taxation decreased to £39.8 million from £71.3 million. Despite the profit decline, adjusted operating profit rose 2.4% to £82.2 million, and the company increased its final dividend to 17.1p per share, signaling confidence in long-term performance and reaffirming its mid-term growth and margin targets.

Analysis

Oxford Instruments plc (OXIG.L) reported a mixed financial performance for fiscal year 2025, characterized by robust revenue growth alongside a significant decline in statutory pre-tax profit. Revenue surpassed the £500 million threshold for the first time, increasing 6.4% year-over-year to £500.6 million, supported by a 6.5% revenue increase at OCC and a 1% growth in orders to £463.7 million. However, profit before taxation fell sharply to £39.8 million from £71.3 million in the prior year, with earnings per share correspondingly dropping to 44.3p from 86.5p. In contrast, adjusted metrics demonstrated resilience: adjusted profit before taxation remained stable at £83.4 million, compared to £83.3 million previously, and adjusted earnings per share rose to 111.1p from 107.5p. Adjusted operating profit also saw a modest increase of 2.4% year-over-year to £82.2 million. The company signaled confidence in its long-term prospects by increasing its total dividend by 6.7% to 22.2p per share and announcing plans to shortly commence an up to £50 million share buyback program. Management reiterated its commitment to mid-term targets, including 5-8% compound annual organic revenue growth and an adjusted operating margin improvement to over 20%, citing a robust order book that provides good visibility for the year ahead.

Key Decisions for Investors

• Investors should scrutinize the factors contributing to the significant divergence between statutory and adjusted profit figures to fully understand the underlying profitability and ascertain the nature of any exceptional items.
• The combination of record revenue, an increased dividend, a planned share buyback, and a confident outlook provides positive signals, though these should be carefully weighed against the sharp decline in reported statutory profit.
• It is prudent to monitor the company's execution on its stated mid-term objectives, particularly the achievement of 5-8% CAGR organic revenue growth and the targeted improvement in adjusted operating margin to above 20%, as these are key determinants for future valuation.